Literature DB >> 9861024

Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase.

N Bergeron1, L Kotite, M Verges, P Blanche, R L Hamilton, R M Krauss, A Bensadoun, R J Havel.   

Abstract

Remnants of triglyceride-rich lipoproteins containing apolipoprotein (apo) B-48 accumulate in apo E-deficient mice, causing pronounced hypercholesterolemia. Mice doubly deficient in apo E and hepatic lipase have more pronounced hypercholesterolemia, even though remnants do not accumulate appreciably in mice deficient in hepatic lipase alone. Here we show that the doubly deficient mice manifest a unique lamellar hyperlipoproteinemia, characterized by vesicular particles 600 A-1,300 A in diameter. As seen by negative-staining electron microscopy, these lipoproteins also contain an electron-lucent region adjacent to the vesicle wall, similar to the core of typical lipoproteins. Correlative chemical analysis indicates that the vesicle wall is composed of a 1:1 molar mixture of cholesterol and phospholipids, whereas the electron-lucent region appears to be composed of cholesteryl esters (about 12% of the particle mass). Like the spherical lipoproteins of doubly deficient mice, the vesicular particles contain apo B-48, but they are particularly rich in apo A-IV. We propose that cholesteryl esters are removed from spherical lipoproteins of these mice by scavenger receptor B1, leaving behind polar lipid-rich particles that fuse to form vesicular lipoproteins. Hepatic lipase may prevent such vesicular lipoproteins from accumulating in apo E-deficient mice by hydrolyzing phosphatidyl choline as scavenger receptor B1 removes the cholesteryl esters and by gradual endocytosis of lipoproteins bound to hepatic lipase on the surface of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861024      PMCID: PMC28098          DOI: 10.1073/pnas.95.26.15647

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

2.  Validation of a procedure for exogenous isotopic labeling of lipoprotein triglyceride with radioactive triolein.

Authors:  C J Fielding
Journal:  Biochim Biophys Acta       Date:  1979-05-25

3.  Unilamellar liposomes made with the French pressure cell: a simple preparative and semiquantitative technique.

Authors:  R L Hamilton; J Goerke; L S Guo; M C Williams; R J Havel
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

4.  Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad.

Authors:  C Glass; R C Pittman; D B Weinstein; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

5.  Cholestasis: lamellar structure of the abnormal human serum lipoprotein.

Authors:  R L Hamilton; R J Havel; J P Kane; A E Blaurock; T Sata
Journal:  Science       Date:  1971-04-30       Impact factor: 47.728

6.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans.

Authors:  R M Krauss; D J Burke
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

7.  Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.

Authors:  G Ghiselli; E J Schaefer; P Gascon; H B Breser
Journal:  Science       Date:  1981-12-11       Impact factor: 47.728

8.  The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts.

Authors:  F Roerdink; J Dijkstra; G Hartman; B Bolscher; G Scherphof
Journal:  Biochim Biophys Acta       Date:  1981-09-18

9.  Enzyme-linked immunosorbent assay for rat hepatic triglyceride lipase.

Authors:  L A Cisar; A Bensadoun
Journal:  J Lipid Res       Date:  1985-03       Impact factor: 5.922

10.  Metabolism of chromatographically separated rat serum lipoproteins specifically labeled with 125I-apolipoprotein E.

Authors:  F van't Hooft; R J Havel
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

View more
  9 in total

1.  Speciated human high-density lipoprotein protein proximity profiles.

Authors:  Kekulawalage Gauthamadasa; Corina Rosales; Henry J Pownall; Stephen Macha; W Gray Jerome; Rong Huang; R A Gangani D Silva
Journal:  Biochemistry       Date:  2010-11-23       Impact factor: 3.162

2.  Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function.

Authors:  Angel C Y Mak; Clive R Pullinger; Ling Fung Tang; Jinny S Wong; Rahul C Deo; Jean-Marc Schwarz; Alejandro Gugliucci; Irina Movsesyan; Brian Y Ishida; Catherine Chu; Annie Poon; Phillip Kim; Eveline O Stock; Ernst J Schaefer; Bela F Asztalos; Joseph M Castellano; Tony Wyss-Coray; Jacque L Duncan; Bruce L Miller; John P Kane; Pui-Yan Kwok; Mary J Malloy
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

3.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.

Authors:  X C Jiang; C Bruce; J Mar; M Lin; Y Ji; O L Francone; A R Tall
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E.

Authors:  Tao Fu; Papreddy Kashireddy; Jayme Borensztajn
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

5.  Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse.

Authors:  Anne Braun; Songwen Zhang; Helena E Miettinen; Shamsah Ebrahim; Teresa M Holm; Eliza Vasile; Mark J Post; Danita M Yoerger; Michael H Picard; Joshua L Krieger; Nancy C Andrews; Michael Simons; Monty Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

6.  Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.

Authors:  Zengxuan Nong; Herminia Gonzalez-Navarro; Marcelo Amar; Lita Freeman; Catherine Knapper; Edward B Neufeld; Beverly J Paigen; Robert F Hoyt; Jamila Fruchart-Najib; Silvia Santamarina-Fojo
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

7.  Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content.

Authors:  Eva Pardina; Juan A Baena-Fustegueras; Roberto Catalán; Rosa Galard; Albert Lecube; Jose M Fort; Helena Allende; Víctor Vargas; Julia Peinado-Onsurbe
Journal:  Obes Surg       Date:  2008-10-30       Impact factor: 4.129

8.  Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing.

Authors:  Bradley O Elmore; Kathleen D Triplett; Pamela R Hall
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

9.  Gall Wasp Transcriptomes Unravel Potential Effectors Involved in Molecular Dialogues With Oak and Rose.

Authors:  Sébastien Cambier; Olivia Ginis; Sébastien J M Moreau; Philippe Gayral; Jack Hearn; Graham N Stone; David Giron; Elisabeth Huguet; Jean-Michel Drezen
Journal:  Front Physiol       Date:  2019-07-24       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.